These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 21214874

  • 21. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
    Maeda Y, Elborn JS, Parkins MD, Reihill J, Goldsmith CE, Coulter WA, Mason C, Millar BC, Dooley JS, Lowery CJ, Ennis M, Rendall JC, Moore JE.
    J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
    [Abstract] [Full Text] [Related]

  • 22. Acetaldehyde production from ethanol by oral streptococci.
    Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K, Rautemaa R, Grönroos L, Meurman JH, Salaspuro M.
    Oral Oncol; 2007 Feb; 43(2):181-6. PubMed ID: 16859955
    [Abstract] [Full Text] [Related]

  • 23. Fluorescence Tools Adapted for Real-Time Monitoring of the Behaviors of Streptococcus Species.
    Shields RC, Kaspar JR, Lee K, Underhill SAM, Burne RA.
    Appl Environ Microbiol; 2019 Aug 01; 85(15):. PubMed ID: 31101614
    [Abstract] [Full Text] [Related]

  • 24. Biofilm Interactions of Candida albicans and Mitis Group Streptococci in a Titanium-Mucosal Interface Model.
    Souza JGS, Bertolini M, Thompson A, Barão VAR, Dongari-Bagtzoglou A.
    Appl Environ Microbiol; 2020 Apr 17; 86(9):. PubMed ID: 32111586
    [Abstract] [Full Text] [Related]

  • 25. Identification of Anion Channels Responsible for Fluoride Resistance in Oral Streptococci.
    Men X, Shibata Y, Takeshita T, Yamashita Y.
    PLoS One; 2016 Apr 17; 11(11):e0165900. PubMed ID: 27824896
    [Abstract] [Full Text] [Related]

  • 26. Oral challenge with Streptococcus sanguinis induces aortic inflammation and accelerates atherosclerosis in spontaneously hyperlipidemic mice.
    Hashizume-Takizawa T, Yamaguchi Y, Kobayashi R, Shinozaki-Kuwahara N, Saito M, Kurita-Ochiai T.
    Biochem Biophys Res Commun; 2019 Dec 10; 520(3):507-513. PubMed ID: 31610917
    [Abstract] [Full Text] [Related]

  • 27. Involvement of antigen I/II surface proteins in Streptococcus mutans and Streptococcus intermedius biofilm formation.
    Pecharki D, Petersen FC, Assev S, Scheie AA.
    Oral Microbiol Immunol; 2005 Dec 10; 20(6):366-71. PubMed ID: 16238597
    [Abstract] [Full Text] [Related]

  • 28. Differential interactions of Streptococcus gordonii and Staphylococcus aureus with cultured osteoblasts.
    Jauregui CE, Mansell JP, Jepson MA, Jenkinson HF.
    Mol Oral Microbiol; 2013 Aug 10; 28(4):250-66. PubMed ID: 23413785
    [Abstract] [Full Text] [Related]

  • 29. Amino Sugars Reshape Interactions between Streptococcus mutans and Streptococcus gordonii.
    Chen L, Walker AR, Burne RA, Zeng L.
    Appl Environ Microbiol; 2020 Dec 17; 87(1):. PubMed ID: 33097515
    [Abstract] [Full Text] [Related]

  • 30. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
    Rozkiewicz D, Daniluk T, Sciepuk M, Zaremba ML, Cylwik-Rokicka D, Luczaj-Cepowicz E, Milewska R, Marczuk-Kolada G, Stokowska W.
    Adv Med Sci; 2006 Dec 17; 51 Suppl 1():191-5. PubMed ID: 17460837
    [Abstract] [Full Text] [Related]

  • 31. Adhesion and biofilm formation by oral streptococci on different commercial brackets.
    Passariello C, Gigola P.
    Eur J Paediatr Dent; 2013 Jun 17; 14(2):125-30. PubMed ID: 23758462
    [Abstract] [Full Text] [Related]

  • 32. Role of sucrose in the fitness of Streptococcus mutans.
    Kreth J, Zhu L, Merritt J, Shi W, Qi F.
    Oral Microbiol Immunol; 2008 Jun 17; 23(3):213-9. PubMed ID: 18402607
    [Abstract] [Full Text] [Related]

  • 33. Rapid tissue factor induction by oral streptococci and monocyte-IL-1beta.
    Hahn CL, Best AM, Tew JG.
    J Dent Res; 2007 Mar 17; 86(3):255-9. PubMed ID: 17314258
    [Abstract] [Full Text] [Related]

  • 34. Mannosidase production by viridans group streptococci.
    Homer KA, Roberts G, Byers HL, Tarelli E, Whiley RA, Philpott-Howard J, Beighton D.
    J Clin Microbiol; 2001 Mar 17; 39(3):995-1001. PubMed ID: 11230417
    [Abstract] [Full Text] [Related]

  • 35. [Streptococcus mutans and oral streptococci in dental plaque].
    Nicolas GG, Lavoie MC.
    Can J Microbiol; 2011 Jan 17; 57(1):1-20. PubMed ID: 21217792
    [Abstract] [Full Text] [Related]

  • 36. Cytokine release and mitogenic activity in the viridans streptococcal shock syndrome.
    Soto A, McWhinney PH, Kibbler CC, Cohen J.
    Cytokine; 1998 May 17; 10(5):370-6. PubMed ID: 9619375
    [Abstract] [Full Text] [Related]

  • 37. A quantitative approach to the effectiveness of ozone against microbiota organisms colonizing toothbrushes.
    Bezirtzoglou E, Cretoiu SM, Moldoveanu M, Alexopoulos A, Lazar V, Nakou M.
    J Dent; 2008 Aug 17; 36(8):600-5. PubMed ID: 18502558
    [Abstract] [Full Text] [Related]

  • 38. A scheme for the identification of viridans streptococci.
    Beighton D, Hardie JM, Whiley RA.
    J Med Microbiol; 1991 Dec 17; 35(6):367-72. PubMed ID: 1753394
    [Abstract] [Full Text] [Related]

  • 39. Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci.
    Moet GJ, Dowzicky MJ, Jones RN.
    Diagn Microbiol Infect Dis; 2007 Mar 17; 57(3):333-6. PubMed ID: 16989974
    [Abstract] [Full Text] [Related]

  • 40. Differentiation of mutans streptococci by intact cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Rupf S, Breitung K, Schellenberger W, Merte K, Kneist S, Eschrich K.
    Oral Microbiol Immunol; 2005 Oct 17; 20(5):267-73. PubMed ID: 16101961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.